GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:DRNA
Delisted

Dicerna Pharmaceuticals Stock Price (Quote)

$38.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.22 $38.22 Friday, 27th May 2022 DRNA stock ended at $38.22. During the day the stock fluctuated 0% from a day low at $38.22 to a day high of $38.22.
90 days $38.22 $38.22
52 weeks $19.06 $40.14

Historical Dicerna Pharmaceuticals prices

Date Open High Low Close Volume
2021-07-08 $37.02 $38.10 $36.52 $38.01 690 253
2021-07-07 $37.15 $38.03 $36.73 $37.89 603 416
2021-07-06 $37.89 $39.67 $36.51 $37.05 759 350
2021-07-02 $37.60 $38.20 $36.71 $37.77 767 661
2021-07-01 $37.50 $38.12 $36.74 $37.70 430 339
2021-06-30 $36.18 $37.75 $36.14 $37.32 848 778
2021-06-29 $36.67 $37.05 $35.94 $35.99 482 328
2021-06-28 $37.25 $37.52 $36.06 $36.55 720 789
2021-06-25 $38.29 $38.37 $37.43 $37.49 1 012 322
2021-06-24 $37.60 $38.64 $37.16 $38.28 412 304
2021-06-23 $37.50 $37.99 $36.75 $37.04 495 333
2021-06-22 $37.64 $37.64 $36.17 $37.21 650 120
2021-06-21 $36.44 $37.88 $35.61 $37.43 748 505
2021-06-18 $35.54 $36.55 $35.17 $36.18 1 541 675
2021-06-17 $35.65 $36.87 $35.33 $35.78 476 963
2021-06-16 $35.23 $36.76 $34.50 $35.54 1 316 031
2021-06-15 $38.20 $38.22 $35.56 $35.74 705 248
2021-06-14 $37.17 $38.07 $37.03 $38.04 827 950
2021-06-11 $34.00 $37.44 $33.33 $37.36 1 149 371
2021-06-10 $32.58 $33.58 $32.11 $33.56 490 533
2021-06-09 $33.09 $33.62 $32.36 $32.63 381 076
2021-06-08 $33.19 $33.78 $31.91 $32.98 597 785
2021-06-07 $31.18 $33.27 $31.12 $32.97 759 904
2021-06-04 $30.69 $31.36 $30.40 $31.10 318 331
2021-06-03 $30.16 $30.61 $29.60 $30.47 281 762
Click to get the best stock tips daily for free!

About Dicerna Pharmaceuticals

Dicerna Pharmaceuticals Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. The company’s development programs include DCR-PH1 for the treatment of primary hyperoxaluria type 1 (PH1) through targeting the gene encoding the liver enzyme glycolate oxidase; and other rare inherit... DRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT